UOC
ACGN

UBS O'Connor’s Aceragen Inc ACGN Stock Holding History

UBS O'Connor’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-368
Closed -$220K – 875
2014
Q4 		$220K Buy
+368
New +$148K ﹤0.01% 592

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS O'Connor's ACGN Position: Q1 2015 in Review

UBS O'Connor sold out of Aceragen Inc (ACGN) in Q1 2015, closing a stake of 368 shares — an estimated $220K sold.

UBS O'Connor first reported a position in ACGN in Q4 2014 and held it in 1 quarter. The position peaked at $220K in Q4 2014. 78 funds tracked by Wall St. Rank hold ACGN as of Q1 2015.

  • UBS O'Connor reported no remaining Aceragen Inc position as of Q1 2015 after selling out during the quarter.
  • UBS O'Connor sold 368 Aceragen Inc shares in Q1 2015, an estimated $220K.
  • UBS O'Connor first reported a position in Aceragen Inc in Q4 2014 and held it in 1 quarter.
  • UBS O'Connor's Aceragen Inc position peaked at $220K in Q4 2014.
  • 78 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2015.

Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.